title: Thiamine deficiency appears uncommon in patients with Myeloproliferative Neoplasms.
authors.affiliation: Department of Haematology, Royal Free London NHS Foundation Trust, London, UK.
authors.forename: Natalia
authors.initials: N
authors.lastname: Curto-García
authors.affiliation: Department of Haematology, Guy's and St. Thomas NHS Foundation Trust, London, UK.
authors.forename: Claire N
authors.initials: CN
authors.lastname: Harrison
authors.affiliation: Department of Haematology, Guy's and St. Thomas NHS Foundation Trust, London, UK.
authors.forename: Donal P
authors.initials: DP
authors.lastname: McLornan
authors.affiliation: Department of Haematology, Guy's and St. Thomas NHS Foundation Trust, London, UK.
authors.forename: Deepti H
authors.initials: DH
authors.lastname: Radia
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D009196:Myeloproliferative Disorders / Q000097:blood* / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D013831:Thiamine / Q000097:blood*; D013832:Thiamine Deficiency / Q000097:blood* / Q000175:diagnosis / Q000209:etiology*
chemical_list: D047428:Protein Kinase Inhibitors; D013831:Thiamine
keywords: JAK1/2 inhibitor; fedratinib; myelofibrosis; thiamine